LoadingLoadingLoadingNet buying: insiders sold $2.7M and bought $157M on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (1)
FMR LLC
$3.8M
added
Sells/Trims (2)
Citadel
$27.1M
trimmed
Balyasny
$25.9M
trimmed
Buys (2)
Baker Bros. Advisors Lp
$63.4M
bought
Baker Bros. Advisors Lp
$58.6M
bought
Sells (1)
Borgeson John A.
$2.7M
sold
No tracked top-trader positions in KOD as of Oct 24, 10:57 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Aug 12, 2026
Period ending
Jun 30, 2026
Earnings per share
EPS comparison unavailable
Revenue
Financial statements: Alpha Vantage
Estimates as of Oct 22, 2026
EPS expected
-$1.10 to -$0.89
Last 30 days
Analysts cutting estimates
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 12, 2026 | Unavailable | - | $0.00 No estimate | Unavailable |
| Mar 31, 2026 | May 7, 2026 | -$0.94 / -$1.01Alpha Vantage | +6.93% beat | $0.00 No estimate | Unavailable |
| Dec 31, 2025 | Mar 31, 2026 | -$1.04 / -$1.01Alpha Vantage | -2.97% miss | $0.00 No estimate | Unavailable |
| Sep 30, 2025 | Nov 13, 2025 | -$1.16 / -$1.04Alpha Vantage | -11.54% miss | $0.00 No estimate | Unavailable |
| Jun 30, 2025 | Aug 13, 2025 | -$1.03 / -$1.05Alpha Vantage | +1.90% beat | $0.00 No estimate | Unavailable |
| Mar 31, 2025 | May 14, 2025 | -$1.09 / -$0.87Alpha Vantage | -25.29% miss | $0.00 No estimate | Unavailable |
| Dec 31, 2024 | Mar 27, 2025 | -$0.84 / -$0.86Alpha Vantage | +2.78% beat | $26.7M No estimate | Unavailable |
| Sep 30, 2024 | Nov 14, 2024 | -$0.84 / -$0.90Alpha Vantage | +6.67% beat | $0.00 No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $0 | $0 | $0 | $0 |
| Cost of what it sold | $6.5M | -$19.8M | $6.3M | — |
| Gross profit | -$6.5M | $19.8M | -$6.3M | — |
| What it spent | ||||
| Research and development | $50.5M | $45.5M | $48.5M | $56.1M |
| Sales and admin | $11.9M | $12.0M | $11.2M | $10.8M |
| Total operating expenses | $62.4M | $57.5M | $59.8M | $66.8M |
| What was left | ||||
| Operating profit | -$62.4M | -$57.5M | -$59.8M | -$66.8M |
| Profit before tax | -$61.5M | -$56.7M | -$58.2M | -$65.6M |
| Net profit | -$61.5M | -$56.7M | -$58.2M | -$65.6M |
| EBITDA | -$54.9M | -$46.5M | -$51.8M | -$60.6M |
This stock is trending upward.
Trend
Constructive
65 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Form 144 KODIAK SCIENCES INC. For: 21 October By Investing.com
NeutralOct 22Form S-3ASR Kodiak Sciences Inc For: 20 October By Investing.com
NeutralOct 21Kodiak Sciences Inc. (KOD) files mixed shelf
NeutralOct 21Form S-3ASR Kodiak Sciences Inc For: 20 October By Investing.com
NeutralOct 21KOD Stock Explodes As Zenkuda Trial Data Rewire Wall Street
BullishOct 19H.C. Wainwright raises Kodiak Sciences stock target to USD 126.00
NeutralOct 18How Investors May Respond To Kodiak Sciences Stock After Wet AMD Trial Success
Leans bullishOct 18Kodiak Sciences Inc. (KOD) options chain
NeutralOct 1610 macro signals shaping KOD right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
